🔎 Trials Near Me

Domov › Rakovina obličiek (renálny bunkový karcinóm) › Texas › Dallas

Klinické štúdie Rakovina obličiek (renálny bunkový karcinóm) v meste Dallas, TX

23 štúdií pre Rakovina obličiek (renálny bunkový karcinóm) hľadá účastníkov v zariadeniach v meste Dallas a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Prebieha náborFáza 1
  • NEO-811 Dallas Site, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Prebieha náborFáza 1
  • Texas Oncology, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Prebieha náborFáza 1
  • Exelixis Clinical Site #89, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Prebieha náborFáza 2
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382

DESTINY-PANTUMOUR04

Prebieha náborObservačná štúdia
  • Research Site, Dallas
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Prebieha náborFáza 1/2
  • Baylor, Scott and White Research Institute, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06047379

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Prebieha náborFáza 2
  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Prebieha náborFáza 1/2
  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
  • University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
  • a 2 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07227415

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

Prebieha náborFáza 2
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05319015

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Prebieha náborObservačná štúdia
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Prebieha náborFáza 1/2
  • Mary Crowley Cancer Research, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06750185

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Prebieha náborFáza 3
  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06661720

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Prebieha náborFáza 2
  • University of Texas, Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT05361720

PET/MR for Characterization of Renal Masses (RMs)

Prebieha náborObservačná štúdia
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06076538

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Prebieha náborFáza 1
  • UT Southwestern Simmons Cancer Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 6. 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Prebieha náborFáza 1
  • University of Texas Southwestern Medical Center /ID# 251974, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Prebieha náborFáza 2
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 5. 2026 · NCT06053658

A Study of VET3-TGI in Patients With Solid Tumors

Prebieha náborFáza 1
  • Mary Crowley Cancer Research, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 4. 2026 · NCT06444815

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Prebieha náborVítaní zdravých dobrovoľníkov
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 1. 2026 · NCT04623502

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

Prebieha náborFáza 1
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 12. 2025 · NCT04989959

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Prebieha náborFáza 2
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 11. 2025 · NCT06601296

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

Prebieha náborFáza 2
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 10. 2025 · NCT05931393

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Prebieha náborFáza 3
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT04510597

Štúdie Rakovina obličiek (renálny bunkový karcinóm) v iných mestách

Iné štúdie v Dallas

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.